Robert A. Fridell

5.7k citations

53 papers · 4.5k indexed · 1 hit paper · h-index 31

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
Virology top 1%
- HIV Research and Treatment

Papers in

Hepatology 24
- Hepatitis C virus research 24
Virology 14
- HIV Research and Treatment 14

Co-authors: Bryan R. Cullen Hal P. Bogerd Chunfu Wang R. Edward Benson Lourdes Valera Dike Qiu Donald R. O’Boyle Jin-Hua Sun
Journals: Antimicrobial Agents and Chemotherapy (8 papers)Journal of Virology (5 papers)Molecular and Cellular Biology (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Hepatology (3 papers)
Partner nations: United States Germany United Kingdom

In The Last Decade

Robert A. Fridell

53 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect 2010 · 689 citations

Peers

Countries citing papers authored by Robert A. Fridell

Since Specialization

Citations

This map shows the geographic impact of Robert A. Fridell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Fridell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Fridell more than expected).

Fields of papers citing papers by Robert A. Fridell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Fridell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Fridell. The network helps show where Robert A. Fridell may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. Fridell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Fridell Line = papers co-authored together Robert A. Fridell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The HIV-1 Capsid-Targeted Inhibitor GSK878 Alters Selection of Target Sites for HIV DNA Integration AIDS Research and Human Retroviruses ·Kaitlin A. Marquis, J.K. Everett, Adrian Cantu, Alexander McFarland, Scott Sherrill-Mix, Mark Krystal, Kyle Parcella, Eric P. Gillis, Robert A. Fridell, Frederic D. Bushman	2023	4
2	Resistance Analysis of Hepatitis C Virus Genotype 1 Prior Treatment Null Responders Receiving Daclatasvir And Asunaprevir Hepatology ·Fiona McPhee, Dennis Hernandez, Fei Yu, Joseph Ueland, Aaron Monikowski, Arlene Carifa, Paul Falk, Chunfu Wang, Robert A. Fridell, Timothy Eley, Nannan Zhou, David Gardiner	2013	98
3	Characterizations of HCV NS5A replication complex inhibitors Virology ·Donald R. O’Boyle, Jin-Hua Sun, Peter T. Nower, Julie A. Lemm, Robert A. Fridell, Chunfu Wang, J. Romine, Makonen Belema, Van N. Nguyen, Denis R. St. Laurent, Michael H. Serrano‐Wu, Lawrence B. Snyder, Nicholas A. Meanwell, David R. Langley, Min Gao	2013	35
4	Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir Antimicrobial Agents and Chemotherapy ·Chunfu Wang, Jin-Hua Sun, Donald R. O’Boyle, Peter T. Nower, Lourdes Valera, Susan B. Roberts, Robert A. Fridell, Min Gao	2013	80
5	Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052 Hepatology ·Jin-Hua Sun, Donald R. O’Boyle, Yan Zhang, Chunfu Wang, Peter T. Nower, Lourdes Valera, Susan B. Roberts, Richard E. Nettles, Robert A. Fridell, Min Gao	2012	41
6	HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies Bioorganic & Medicinal Chemistry Letters ·Omar D. Lopez, Van N. Nguyen, Denis R. St. Laurent, Makonen Belema, Michael H. Serrano‐Wu, Jason T. Goodrich, Fukang Yang, Yuping Qiu, Amy S. Ripka, Peter T. Nower, Lourdes Valera, Mengping Liu, Donald R. O’Boyle, Jin-Hua Sun, Robert A. Fridell, Julie A. Lemm, Min Gao, Andrew C. Good, Nicholas A. Meanwell, Lawrence B. Snyder	2012	23
7	Synthesis and SAR studies of novel heteroaryl fused tetracyclic indole-diamide compounds: Potent allosteric inhibitors of the hepatitis C virus NS5B polymerase Bioorganic & Medicinal Chemistry Letters ·Min Ding, Feng He, Thomas W. Hudyma, Xiaofan Zheng, Michael A. Poss, John F. Kadow, Brett R. Beno, Karen Rigat, Ying-Kai Wang, Robert A. Fridell, Julie A. Lemm, Dike Qiu, Mengping Liu, Stacey Voss, Lenore A. Pelosi, Susan B. Roberts, Min Gao, Jay O. Knipe, Robert G. Gentles	2012	15
8	The synthesis of novel heteroaryl-fused 7,8,9,10-tetrahydro-6H-azepino[1,2-a]indoles, 4-oxo-2,3-dihydro-1H-[1,4]diazepino[1,7-a]indoles and 1,2,4,5-tetrahydro-[1,4]oxazepino[4,5-a]indoles. Effective inhibitors of HCV NS5B polymerase Organic & Biomolecular Chemistry ·Min Ding, Feng He, Michael A. Poss, Karen Rigat, Ying-Kai Wang, Susan B. Roberts, Dike Qiu, Robert A. Fridell, Min Gao, Robert G. Gentles	2011	22
9	The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization Journal of General Virology ·Dike Qiu, Julie A. Lemm, Donald R. O’Boyle, Jin-Hua Sun, Peter T. Nower, Van Nguyen, Lawrence G. Hamann, Lawrence B. Snyder, Daniel H. Deon, Edward H. Ruediger, Nicholas A. Meanwell, Makonen Belema, Min Gao, Robert A. Fridell	2011	44
10	The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors Bioorganic & Medicinal Chemistry Letters ·Scott Martin, Peter W. Glunz, Brett R. Beno, Carl P. Bergstrom, J. Romine, E. Scott Priestley, Makenzie Newman, Min Gao, Susan B. Roberts, Karen Rigat, Robert A. Fridell, Dike Qiu, Galina Knobloh, Ying-Kai Wang	2011	11
11	Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations Hepatology ·Robert A. Fridell, Chunfu Wang, Jin-Hua Sun, Donald R. O’Boyle, Peter T. Nower, Lourdes Valera, Dike Qiu, Susan B. Roberts, Xin Huang, Bernadette Kienzle, Marc Bifano, Richard E. Nettles, Min Gao	2010	186
12	Replication-Competent Chimeric Hepatitis C Virus Subgenomic Replicons Intervirology ·Julie A. Lemm, Mengping Liu, Ronald E. Rose, Robert A. Fridell, Donald R. O’Boyle, Richard J. Colonno, Min Gao	2005	16
13	A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding Proceedings of the National Academy of Sciences ·Pin‐Fang Lin, Wade Blair, Tao Wang, Timothy Spicer, Qi Guo, Nannan Zhou, Yi-Fei Gong, H.-G. Heidi Wang, Ronald E. Rose, Gregory Yamanaka, Brett S. Robinson, Changben Li, Robert A. Fridell, Carol Deminie, G W Demers, Zheng Yang, Lisa Zadjura, Nicholas A. Meanwell, Richard J. Colonno	2003	285
14	Myosin XVA Expression in the Pituitary and in Other Neuroendocrine Tissues and Tumors American Journal Of Pathology ·Ricardo V. Lloyd, Sergio Vidal, Long Jin, Shuya Zhang, Kálmán Kovács, Éva Horváth, Bernd W. Scheithauer, Erich T. Boger, Robert A. Fridell, Thomas B. Friedman	2001	17
15	Characterization of the Human and Mouse Unconventional Myosin XV Genes Responsible for Hereditary Deafness DFNB3 and Shaker 2 Genomics ·Yong Liang, Aihui Wang, Inna A. Belyantseva, David W. Anderson, Frank J. Probst, Thomas D. Barber, Webb Miller, Jeffrey W. Touchman, Long Jin, Susan L. Sullivan, James R. Sellers, Sally A. Camper, Ricardo V. Lloyd, Bechara Kachar, Thomas B. Friedman, Robert A. Fridell	1999	128
16	Identification and Functional Characterization of a Novel Nuclear Localization Signal Present in the Yeast Nab2 Poly(A) ⁺ RNA Binding Protein Molecular and Cellular Biology ·Ray Truant, Robert A. Fridell, R. Edward Benson, Hal P. Bogerd, Bryan R. Cullen	1998	60
17	Nudeocytoplasmic shuttling by protein nuclear import factors European Journal of Cell Biology ·Ray Truant, Robert A. Fridell, Edward R. Benson, Andrea Herold, Bryan R. Cullen	1998	12
18	A nuclear role for the Fragile X mental retardation protein. The EMBO Journal ·Robert A. Fridell, R. Edward Benson, Jian Hua, Hal P. Bogerd, Bryan R. Cullen	1996	110
19	Structure and Transcription of the Drosophila melanogaster Vermilion Gene and Several Mutant Alleles Molecular and Cellular Biology ·Lillie L. Searles, Richard S. Ruth, Anne‐Marie Pret, Robert A. Fridell, Ahmad J. Ali	1990	19
20	Absence of in-vitro fluoride-binding by the organic matrix of developing bovine enamel Archives of Oral Biology ·Adrian Lussi, Robert A. Fridell, M.A. Crenshaw, J.W. Bawden	1988	14

About Robert A. Fridell

Robert A. Fridell is a scholar working on Hepatology, Virology, Infectious Diseases, Sensory Systems and Epidemiology, having authored 53 papers that have together received 4.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (24 papers), HIV/AIDS drug development and treatment (19 papers), Hepatitis B Virus Studies (16 papers), HIV Research and Treatment (14 papers), RNA Research and Splicing (10 papers), Nuclear Structure and Function (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and RNA and protein synthesis mechanisms (4 papers). The work is most often cited by research in Hepatology (1.7k citations), Virology (644 citations), Sensory Systems (558 citations), Infectious Diseases (1.1k citations) and Epidemiology (1.5k citations). Robert A. Fridell has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Bryan R. Cullen, Hal P. Bogerd, Chunfu Wang, R. Edward Benson, Lourdes Valera, Dike Qiu, Donald R. O’Boyle, Jin-Hua Sun, Jian Hua and Min Gao. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Virology, Molecular and Cellular Biology, Bioorganic & Medicinal Chemistry Letters and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact